ME/CFS Day May 12, 2021

May 12th is the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) International Awareness Day. As we mark this day each year, we highlight how you can support the millions of people globally (and at least 25,000 here in NZ) who suffer from ME/CFS. We mark this day on Florence Nightingale’s birthday, because it is thought that she developed ME/CFS after an infection contracted during the Crimean War.

ME/CFS is a serious, disabling, long-term disease which affects multiple bodily systems (immune, endocrine, neurological and autonomic). [1] The World Health Organisation classified ME/CFS as a neurological disease back in 1969. Despite this, ME/CFS has often been misunderstood, stigmatised as psychosomatic, and underfunded. Today we have a much clearer understanding of the biological basis for the disease through research from the likes of Harvard, Stanford, Cornell, and DePaul universities in the USA, and our very own Emeritus Professor Warren Tate of the University of Otago.

This year, with COVID-19 still present globally, we also want to direct attention to the estimated 25-35% of cases [2] who have not recovered from the virus. Those people who are still unwell 12 weeks after the expected recovery period, are classed as having “Long COVID” and some go on to receive a diagnosis of ME/CFS as well.

There are similarities between ME/CFS and Long COVID (some symptoms overlap):

ME/CFS *Long COVID *
Severe fatigue with post-exertional malaiseFatigue
Cognitive dysfunction (brain fog, memory lapses)Brain fog
Gastrointestinal issuesGastrointestinal issues
shortness of breathshortness of breath
Fevers/ChillsFevers/Chills
* this is not an exhaustive list of symptoms

This is not surprising because a large percentage of those with ME/CFS, develop it after not recovering from a virus such as Epstein Barr/Mononucleosis, SARS-CoV, etc., or from other infectious illnesses such as Lyme disease (Mayo Clinic, 2020).

What does it mean to have ME/CFS? The list above is not exhaustive. Those with ME/CFS also experience significant deep muscular pain and can also experience a varying degree of symptoms that link to dysfunction of distinct systems in the body [3]:

ImmuneNeuroendocrineAutonomic
Recurrent sore throats, flu-like symptoms, tender/swollen lymph nodesThermostatic dysregulation (feverish but with cold extremities (hands, feet), night sweats, intolerance of heat and coldCircadian rhythm dysfunction (exhausted during day, wide awake at night unable to sleep). Unrefreshing sleep
Sensitivities (to light, sound, smells, food, chemicals, medications), eye dysfunctionInformation processing and thinking difficulties, perceptual disturbancesOrthostatic intolerance, irregular heartbeat, low blood pressure, POTS

ME/CFS is a chronic illness, meaning it is long term.

It can be classed as having three distinct levels of symptom severity [4]:

Mild – at least a 50% decrease in pre-illness activity but may still be able to achieve part-time work and activities

Moderate – mostly housebound (can’t attend work/school or do normal activities)

Severe – bedbound and dependent on help with all daily care
(this occurs in approximately 25% of all ME/CFS cases).

ME/CFS knows no bounds – it affects all ages, ethnicities, genders and socioeconomic groups. At this point in time there is no cure, but there is research going on to develop a suitable treatment based on previous research into root cellular causes and dysfunction. Currently Prof. Tate is working on comparing the molecular similarities between ME/CFS and Long COVID patients recruited through the practice of collaborating physician Dr. Rosamund Vallings, in order to not only understand the underlying pathophysiology (root causes and malfunctions) but also to discover potential treatments. [5] Dr. Tate states “Unlike ME/CFS patients who have had their illness from six months to over 40 years in some cases, the long COVID group with post-viral fatigue have been unwell for a relatively short time (up to a year). This is early in the course of what could be a lifelong disease like ME/CFS, so now is the best time to research therapeutic options that might alleviate – and even reverse – the disease.” 

How can you help?
5 ways:

1 Educate – This awareness day, please take time to learn more about ME/CFS and Long COVID by visiting links suggested in this article, by perusing the rest of the ANZMES website and joining our Facebook page: If you or someone you know has ME/CFS share your personal stories with others, on social media, and take time to listen to others’ stories.

2 Support – on May 12th wear BLUE to raise awareness and show support for people with ME/CFS, their families and caregivers as well as the researchers who study ME/CFS. Please use social media to spread information about ME/CFS – share this article, and post photos of you and your family and friends wearing blue. Use hashtags #ISTANDforMECFS #MECFSUnity #ANZMES #BLUEforMECFS #millionsmissing #thelonghaulandME #MEandCOVID #solveMECFS

3 Share our posters and memes and this blog on social media, with friends and family, with your local GP and healthcare providers, and lets show all those living with ME/CFS and Long COVID that they are not alone, they are heard and supported.

Posters:

4 Lobby your local MP to demand that:

  • Evidence-based health guidelines are used by all government agencies to ensure accurate information about ME/CFS for timely diagnosis and management and access to necessary services (including home help and supported living payments)
  • Dedicated research funding is set aside for treatment development
  • ME/CFS is reclassified as a disability so that those unable to work due to the severity of their illness are able to gain access to the services they need.

5 Join our organisation to receive lobbying letter templates, information sheets, and access to the latest news and developments.

We look forward to seeing your presence on social media this May 12th for ME/CFS International Awareness Day 2021. Thank you.


[1] Kerr, J. (2020). https://doi.org/10.3390/biom10111484

[2] http://www.brnz.ac.nz/news-events/brain-research-new-zealand-funds-covid-19-research-projects and https://www.omf.ngo/covid-19-to-me-cfs-study/

[3] For a more comprehensive list visit: https://www.massmecfs.org/cfids-me-cfs?start=1 and https://www.cdc.gov/me-cfs/symptoms-diagnosis/symptoms.html

[4] https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/chronic-fatigue-syndrome-cfs

[5] http://www.brnz.ac.nz/news-events/brain-research-new-zealand-funds-covid-19-research-projects

Awareness Day: Media/Press Release

May 12 marks the international Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Awareness Day, on Florence Nightingale’s birthday (as it is thought she developed ME/CFS after an infection contracted during the Crimean war). Each year on this day ANZMES (the Associated New Zealand ME Society) seeks to provide education and build awareness, as well as advocate for and support those with ME/CFS and their families. This year, with COVID-19 still present globally, attention must also be on those diagnosed with Long COVID. Long COVID will present new challenges. Many of those challenges have already been faced by the ME/CFS community.

Myalgic Encephalomyelitis (ME/CFS) is a serious long-term illness causing disabling symptoms exacerbated by both mental and physical exertion [1]. Despite the person often appearing ‘well’ there are debilitating symptoms that include but are not limited to: incapacitating exhaustion, post-exertional malaise, pain, sleep disturbances, cognitive and gastro-intestinal issues, and orthostatic intolerance (severe light-headedness when standing). The illness affects all genders, races and ethnicities. It affects children, those at university still studying, those just entering the workforce, mums and dads juggling home and work and people at the peak of their careers, right up to the elderly who already have other struggles. Some will recover after some months or years, but those who are still sick two years after onset are likely to suffer this illness for the rest of their lives.  

In NZ there are at least 25,000 people living with ME/CFS – that’s approximately 1 in every 250 adults and 1 in every 134 youth. It commonly has acute onset (occurs suddenly) after a viral illness (e.g. Epstein Barr/Mononucleosis and SARS-CoV) [2]. The COVID-19 virus (SARS-CoV-2) has resulted in a post-viral syndrome for an estimated 25-35% of all cases [3]; a syndrome similar in symptomatology to ME/CFS. Those still unwell twelve weeks after onset [4], are classed as having Long COVID and some go on to receive an ME/CFS diagnosis too. This means the prevalence of ME/CFS in NZ and worldwide is increasing. 

ME-CFS [5]Long COVID [6]
Severe fatigue with post-exertional malaiseFatigue with post-exertional malaise
Cognitive dysfunction (brain fog, memory lapses)Brain fog
Gastrointestinal issuesGastrointestinal issues
shortness of breathshortness of breath
Fevers/ChillsFevers/Chills

There is currently no cure for ME/CFS. However researchers around the world, including Cornell, Stanford and Harvard Universities in the USA, are working to understand the disease, find a diagnostic test and develop more treatments. Despite this, research is woefully underfunded. In the last year The European Union has called for more funding [7]. Researchers here in New Zealand, including a team led by the Rutherford Medal winner Emeritus Professor Warren Tate of the University of Otago, have to rely on donations from people with ME/CFS, their families and organisations such as ANZMES. One such study also funded by Brain Research NZ is to assess the pathophysiological similarities between ME/CFS and those diagnosed with Long COVID [8]. Dr. Tate states “Unlike ME/CFS patients who have had their illness from six months to over 40 years in some cases, the long COVID group with post-viral fatigue have been unwell for a relatively short time (up to a year). This is early in the course of what could be a lifelong disease like ME/CFS, so now is the best time to research therapeutic options that might alleviate – and even reverse – the disease.” [9]

The increase of people with ME/CFS and Long COVID has far-reaching repercussions. For society this means a loss of available people in the workforce and further burdens to the public health system. For the individual it means increased medical costs and a loss of salary. Between 40-81% of those with ME/CFS are unable to maintain employment due to fluctuating, disabling symptoms [10]. A decrease in social contact can result in social isolation, loneliness, and diminished quality-of-life [11]. Even those with ‘mild’ symptoms experience at least a 50% decrease in pre-illness activity [12]. Imagine being unable to meet your friend for coffee at the local café because you don’t even have the energy to shower and dress. Or consider being housebound, not just for a few weeks (like many kiwis experienced during lockdown) but for decades or a lifetime. Imagine the teenager who cannot physically attend school and has to complete coursework from bed. Or picture not being able to play with your children or grandchildren, and missing out on seeing them in school plays and sports. This is the reality for many with ME/CFS.

This year, on the International ME Awareness Day (May 12th), please think about those with ME/CFS and Long COVID, who face ongoing isolation and difficulties associated with living with a chronic illness.

Resources are available for patients, carers, teachers and health professionals through the Associated New Zealand ME Society (ANZMES) at www.anzmes.org.nz.

#myalgicencephalomyelitis #MECFS #LongCOVID #PressRelease #MediaRelease #Fibromyalgia #postexertionalmalaise #millionsmissing #chronicillness #chronicillnesssupport #chronicillnesscommunity #autoimmune #chronicillnesswarriors #endMECFS #openmedicinefoundation #longCOVIDalliance #longhaulers #thelonghaulandME #MEandCovid19 #MEandCOVID #SolveMECFS #WarrenTate #RosVallings #AnnaBrooks #ANZMES #MECFSexperts #nationaladvisoryforMECFS


[1] https://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/symptoms-causes/syc-20360490

[2] Chu, et. al (2019). https://www.frontiersin.org/articles/10.3389/fped.2019.00012/full

[3] Open Medicine Foundation estimates https://www.omf.ngo/covid-19-to-me-cfs-study/

[4] https://www.medicalnewstoday.com/articles/long-covid#definition

[5] For a more comprehensive list visit: https://www.massmecfs.org/cfids-me-cfs?start=1 and https://www.cdc.gov/me-cfs/symptoms-diagnosis/symptoms.html

[6] https://www.pharmaceutical-technology.com/comment/long-covid-complications/

[7] https://www.europarl.europa.eu/news/en/agenda/briefing/2020-06-17/22/myalgic-encephalomyelitis-more-funding-needed-for-research-into-complex-illness

[8] (http://www.brnz.ac.nz/news-events/brain-research-new-zealand-funds-covid-19-research-projects)

[9] https://www.sciencemediacentre.co.nz/2021/04/29/long-covid-in-new-zealand-expert-qa/

[10] Chu, et. al (2019). https://www.frontiersin.org/articles/10.3389/fped.2019.00012/full

[11] Jason, et. al, (2008) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324078/

[12] https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/chronic-fatigue-syndrome-cfs

Upcoming events

Mark your calendar!

Dr. Ros Vallings and Dr. Sarah Dalziel are speaking at some events organised in New Zealand, Australia, and USA over the next few months.

If you’re interested in attending the NZ based talks please contact CCIS. Thank you.

Thursday 13th May 2021 – Dr Vallings to speak in Hamilton for CCIS Waikato providing a research update, and speaking about the implications of Covid-19.
10.30 am at Melville Methodist Church, Bader Street, Hamilton

Friday 14th May 2021 – Dr Sarah Dalziel to speak in an online event with CCIS. Dr Dalziel, is Dr Vallings’ daughter and also has a special interest in ME/CFS. Contact Tabitha if you would like to attend, and to submit your questions for Dr Dalziel: lakes@ccisupport.org.nz

Saturday 3rd July 2021 – CCIS Support 40th Anniversary in Tauranga, Bay of Plenty.
Speakers include Prof. Warren Tate, Dr. Ros Vallings and Dr. Sarah Dalziel. Venue to be arranged.

CCIS logo ferns
Click above to be redirected to CCIS
Dr Ros Vallings
Dr. Ros Vallings


19-21 August 2021 – IACFS Virtual conference (based in USA) – programme to be arranged.
16th and 17th November 2021 – NCNED, Griffith University, Queensland for the 2nd ME/CFS International Conference 2021 – Research Innovation and Discovery – programme to be arranged

Dr. Ros Vallings talk

Dr. Ros Vallings is scheduled to discuss COVID-19 and ME/CFS at a public event on 11th February 2021 in Auckland:

ME Auckland AGM

All are welcome to ME Auckland’s AGM, featuring guest speaker Dr Lynette Hodges.The talk will be held via Zoom. Simply click the link below to join (if joining from mobile, it may ask you to download the Zoom app). Details below 🙂

https://us02web.zoom.us/j/87641407370

Meeting ID: 876 4140 7370

Gavin McGregor’s photography project

ANZMES is supporting Gavin in his project and will be using his work
for awareness raising and to advocate for those with ME/CFS. We thank
Gavin for this opportunity.

I am a photographer working on a portrait series on living with ME/CFS.

For this series, I am looking for people who are willing to sit for a
portrait and talk about how ME/CFS has impacted them.

The purpose of the project is to increase awareness and understanding
of how living with the condition impacts people’s lives in a very real
way.

This series will consist of a portrait series and personal stories of
those living with ME/CFS and will culminate in an online exhibition.
As well as ANZMES having the images and stories for their use as a
resource to further their advocacy work.

My partner lives with ME/CFS so I have an understanding of the
condition and a motivation to increase awareness of it.

If you are interested in being involved and telling your story. Please
don’t hesitate to get in touch

Gavin McGregor
0212774788
gavmc23@mac.com
https://www.gavinmcgregor.com

ANZMES Survey 2020

To be completed and sent in by 15th December 2020

The Survey Link is:

https://www.surveygizmo.com/s3/5728298/ANZMES-Survey-2020

1. It is totally voluntary to complete the survey. 

2.  Completion of the survey is anonymous and so we will not know who has completed the survey or be able to link a person with their responses.

3. All the responses will be joined together so only group information will be used.

4. The final statistics from the survey will be shared with others.  For example it may be shared with the media via a press release. This information will also be used for lobbying. 

We are aware that ME/CFS has a large impact in a variety of areas so we could have included many areas in this survey however, we are also aware that completing a long survey would not be possible for many people with ME/CFS so we have not been able to include all the areas.

We would encourage you to complete the survey, as the more people who complete the survey the more notice others will take of the results. If you know others with ME/CFS please encourage them to complete the survey as well. 

The results will be summarised in the Meeting Place and on the ANZMES website.

ME Day – 12th May 2020

Today, 12th of May 2020 is ME Day!

As part of ANZMES awareness raising we are sending out these posters.

Could you please share them far and wide so many people get the message
that ME is an invisible Illness

You can see a broken leg or arm as you have a cast on but many of the symptoms of ME are invisible and can not be seen.

Sharing these posters helps raise awareness and understanding.

Take Care and be kind to yourselves.

Malcare WordPress Security